Preposition: from

• pancreas: This drug causes production and release of insulin from the pancreas.

Converse of object

• inhale: Inhaled insulins are expected to play an important role in expanding the insulin market.

• longer-act: Your doctor may tell you to use Humalog Pen as well as a longer-acting insulin.

• inject: Holly has to inject insulin several times a day to keep her blood sugar levels under control.

• secrete: This causes cells to store or release calcium which, for example, is the main signal to secrete insulin.

Adjective modifier

• fast-acting: In this test, blood is drawn to measure the blood glucose and cortisol levels, followed by an injection of fast-acting insulin.

• short-acting: Concomitant antidiabetic treatment may need to be adjusted ( dose and timing of concurrent short-acting insulins ).

• soluble: It works very quickly and lasts a shorter time than soluble insulin ( 2 to 5 hours ).

• subcutaneous: Development of such antibodies is seen more commonly in patients treated with EXUBERA compared to subcutaneous insulin.

• porcine: Uses Caninsulin is an intermediate acting insulin product containing porcine insulin, which is structurally identical to canine insulin.

• biphasic: Mixtard 30 is one of the commonly used biphasic insulins.

Modifies a noun

• secretion: This arises from defects in insulin secretion, insulin action or both.

• lispro: Insulin lispro is closely related to human insulin which is a natural hormone made by the pancreas.

• resistance: Insulin Resistance May Be Your Problem Can't Lose Weight?

• injection: People with type 1 diabetes will require insulin injections for the rest of their life.

• detemir: Insulin detemir is a soluble, long-acting basal insulin analog with a prolonged duration of effect.

• sensitivity: By contrast, no effects on body weight gain or insulin sensitivity were observed in female offspring.

Noun used with modifier

• hormone: The body cannot control the sugar in the blood due to the lack of the hormone insulin... .

• serum: No correlation was found between baseline serum insulin and VEGF levels.

• plasma: The improved glycaemic control is associated with a reduction in both fasting and postprandial plasma insulin concentrations.